Matica Biotechnology, Inc. (Matica Bio), a leading contract development and manufacturing organization (CDMO) specializing in ...

The market opportunities lie in expanding GMP-compliant vaccine production facilities globally, ensuring quality raw material supply, and enhancing risk management for safety in production.

Chris McPherson joins as Vice President of GMP Manufacturing, Taleen Barsoumian to serve as Vice President of Client Development, and Adam Davis, Ph.D., promoted to Vice President of Analytical ...

ProBioGen has been selected to operate the process development and GMP production facility for Advanced Therapy Medicinal ...

Traditional microbial expression systems can be advanced through improved plasmid replication, target gene transcription, ...

THE WOODLANDS, Texas and EHIME, Japan, May 8, 2025 /PRNewswire/ -- Cellipont Bioservices, a leading cell therapy Contract Development and Manufacturing Organization (CDMO), and Optieum Biotechnologies ...

Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP) (“Avid”) and Humanigen, Inc. (NASDAQ:HGEN) (“Humanigen”) today announced that they have entered into a manufacturing services agreement to expand ...

THE WOODLANDS, Texas and MIAMI, July 29, 2025 /PRNewswire/ -- Cellipont Bioservices, a leading cell therapy Contract Development and Manufacturing Organization (CDMO) and CellVax Therapeutics Inc., a ...

Marker Therapeutics, Inc. has announced a collaboration with Cellipont Bioservices to support the cGMP manufacturing of MT-601, its lead Multi-Antigen Recognizing (MAR)-T cell therapy, currently in ...

PolyPid (PYPD) announced the successful completion of a routine Good Manufacturing Practice, GMP, inspection by the Israeli ...

PolyPid Ltd. announced on September 16, 2025, the successful completion of a Good Manufacturing Practice (GMP) inspection by the Israeli Ministry of Health, marking its fourth consecutive successful ...